526 Robust prediction of patient outcomes with immune checkpoint blockade therapy for cancer using common clinical, pathologic, and genomic features

• Se-Hoon Lee,
• Diego Chowell,
• Eytan Ruppin,
• Cristina Valero,
• Yingying Cao,
• Luc Morris,
• Saugato R Dhruba,
• Tiangen Chang,
• Hannah Sfreddo,
• Seong-Keun Yoo

Affiliations

Se-Hoon Lee

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, The Republic of Korea

Diego Chowell

Aff11 0000 0001 2171 9952grid.51462.34Memorial Sloan Kettering Cancer Center New York NY USA

Eytan Ruppin

1National Institutes of Health, Bethesda, MD, USA

Cristina Valero

1 Rheumatology Department, Hospital Universitario La Princesa, IIS-IP, Madrid, Spain

Yingying Cao

1National Institutes of Health, Bethesda, MD, USA

Luc Morris

Memorial Sloan Kettering Cancer Center, New York, NY, USA

Saugato R Dhruba

National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

Tiangen Chang

1National Institutes of Health, Bethesda, MD, USA

Hannah Sfreddo

2Memorial Sloan Kettering Cancer Center, New York, NY, USA

Seong-Keun Yoo

2Memorial Sloan Kettering Cancer Center, New York, NY, USA